AiCuris nominates Madam Therapeutics with its innovative peptide approach to fight AMR as the first winner of the AiCubator Resident Status in 2022

08.04.2022 AiCuris nominates Madam Therapeutics with its innovative peptide approach to fight AMR as the first winner of the AiCubator Resident Status in 2022 | AiCuris Anti-infective Cures AG | News | Nachricht | Mitteilung

Related Keywords

Germany ,Japan ,Wuppertal ,Nordrhein Westfalen ,Netherlands ,German ,Remko Van Leeuwen ,Lysando Artilysin ,Holger Zimmermann ,Aicuris Aicubator ,Linkedin ,Madam Therapeutics ,Aicubator Resident Status ,Curis Anti Infective Cures ,Aicuris Anti Infective Cures ,German Future Prize ,German President ,Immune System ,Life Saving Innovation ,Finanznachrichten ,D Hoc ,Aktien ,Ktienkurse ,örse ,Apitalmarktinformationen ,Itteilungen ,Achrichten ,News ,Irtschaft ,